NeuroSense Therapeutics (NRSN) Stock Chart & Stock Price History $1.19 +0.02 (+1.71%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$1.20 +0.01 (+0.42%) As of 08/15/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NeuroSense Therapeutics Stock Price Performance The NeuroSense Therapeutics (NRSN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 54.55%, with a year-to-date return of -0.83%. In the past month, the stock has decreased 39.59%, reflecting recent market activity. As of the latest close, NeuroSense Therapeutics traded at $1.19 with a market cap of $16.27 million and volume of 169,515 shares. Receive NRSN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.25%1 Month Performance-39.59%3 Month Performance-9.85%Year-To-Date Performance-0.83%1 Year Performance+54.55% NRSN Stock Chart for Sunday, August, 17, 2025 NRSN Chart by TradingView NeuroSense Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$1.17$1.19+1.71%$1.23$1.15169,515 shs$16.27 million08/14/2025$1.25$1.17-6.40%$1.29$1.03479,081 shs$15.99 million08/13/2025$1.12$1.25+11.61%$1.31$1.13427,559 shs$17.09 million08/12/2025$1.20$1.12-6.67%$1.22$1.08594,438 shs$15.31 million08/11/2025$1.26$1.20-4.76%$1.28$1.13306,516 shs$16.40 million08/08/2025$1.30$1.26-3.08%$1.33$1.22143,895 shs$17.22 million08/07/2025$1.34$1.30-2.99%$1.39$1.25227,164 shs$17.77 million08/06/2025$1.38$1.34-2.90%$1.52$1.33382,037 shs$18.32 million08/05/2025$1.26$1.38+9.52%$1.39$1.23387,445 shs$18.86 million08/04/2025$1.08$1.26+16.67%$1.29$1.061.17 million shs$17.22 million Get the Latest News and Ratings for NRSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$1.80$1.08-40.00%$1.77$1.001.58 million shs$14.76 million07/31/2025$1.74$1.80+3.45%$1.88$1.73129,431 shs$24.61 million07/30/2025$1.85$1.74-5.95%$1.95$1.69371,297 shs$23.78 million07/29/2025$2.03$1.85-8.87%$2.09$1.85227,366 shs$25.29 million07/28/2025$2.03$2.03$2.04$1.92148,977 shs$27.75 million07/25/2025$2.03$2.03$2.03$1.94225,621 shs$27.75 million07/24/2025$2.05$2.03-0.98%$2.10$1.95247,532 shs$27.75 million07/23/2025$1.93$2.05+6.33%$2.07$1.91564,060 shs$28.02 million07/22/2025$1.93$1.93-0.10%$1.95$1.83447,969 shs$26.36 million07/21/2025$2.04$1.93-5.39%$2.05$1.85386,391 shs$26.38 million07/18/2025$1.97$2.04+3.55%$2.04$1.9784,429 shs$27.89 million07/17/2025$2.03$1.97-2.96%$2.04$1.96109,955 shs$26.92 million07/16/2025$1.98$2.03+2.53%$2.07$1.94118,072 shs$27.75 million Related Companies INMB Stock Chart STRO Stock Chart GNTA Stock Chart ARTV Stock Chart FBRX Stock Chart IMMX Stock Chart MNOV Stock Chart RPTX Stock Chart PYXS Stock Chart ATRA Stock Chart Receive NRSN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRSN) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroSense Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroSense Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access